Close

Search

Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Clinical Deployment of a Platform Technology for Spectroscopic Identification of Diseases

Oct 27, 2021
Facebook Twitter LinkedIn Email Comments
TO VIEW THIS WEBINAR:
Login  Register
ABOUT THIS WEBINAR
Frédéric Leblond describes recent advancements in his group's laboratory that led to the development, technology transfer, and clinical translation of optical spectroscopy instruments to guide surgical procedures, including the resection of tumors (brain, prostate, breast, and ovaries/uterus) and targeted brain needle biopsies. Other work is presented using optical spectroscopy for rapid saliva-based COVID-19 screening and diagnostic/prognostics approaches for improved prostate cancer patient stratification and pediatric focal cortical dysplasia detection using Raman microspectroscopy.

***This presentation premiered during the 2021 BioPhotonics Conference. For more information on Photonics Media conferences, visit events.photonics.com.  

About the presenter:
Frédéric LeblondFrédéric Leblond, Ph.D, is a professor in the Department of Engineering Physics at Polytechnique Montréal and director of the Laboratory for Radiological Optics (LRO). He is also a research scientist at the CRCHUM medical research center and co-founder of the company ODS Medical. He holds a bachelor's degree in engineering physics from Polytechnique Montréal, a master's degree in physics from Laval University, and a doctorate in physics from McGill University. After receiving his doctorate, he was a postdoctoral researcher at The University of Chicago. He was then a senior researcher for three years and worked on the development of medical instruments at a Montreal medical imaging company. Prior to joining Polytechnique, Leblond was a professor of engineering at Dartmouth College in New Hampshire for five years, where he was also affiliated with the Dartmouth-Hitchcock medical center. Leblond's research is related to the development of light-based medical devices to characterize biological tissues to improve the accuracy and safety of surgical procedures, as well as to develop techniques to improve the accuracy of medical diagnostics.
spectroscopyBiophotonicscancercoronavirusCOVID-19Raman microspectroscopyRaman spectroscopysurgery
Photonics Spectra Optics Conference 2022
LATEST HEADLINES
view all
PHOTONICS MARKETPLACE
Search more than 4000 manufacturers and suppliers of photonics products and services worldwide:

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2022 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.